
Here’s what we know about booster shots for Moderna’s and J&J’s COVID-19 vaccines
Millions of people who got Moderna’s or Johnson & Johnson’s COVID-19 vaccines are expected to soon be lining up for another dose.
BALTIMORE, MD, April 7, 2025 – INFORMS, the world’s largest association for professionals and students in operations research (O.R.), AI, analytics and data science, announced it has awarded USA Cycling its 2025 Franz Edelman Award for Achievement in Advanced Analytics, Operations Research and Management Science, for its use of operations research (O.R.) and analytics in elite sports performance. With Project 4:05, USA Cycling transformed race strategy and athlete preparation, enabling the Women’s Team Pursuit to win gold at the 2024 Paris Olympics.
A bipartisan push in Congress would return the power to impose tariffs to the legislature.
The threat of a terrorist attack on America’s energy grid is growing, with attempts being reported at increasing rates. If it’s not terrorism, it could be adversarial nation-states. This all increases the likelihood that a significant attack on the grid could succeed, leaving large swaths of the U.S. in the dark.
An audio journey of how data and analytics save lives, save money and solve problems.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
asmith@informs.org
443-757-3578
Explore our resources for multiple topics including:
Millions of people who got Moderna’s or Johnson & Johnson’s COVID-19 vaccines are expected to soon be lining up for another dose.
Step into one of Maryum Al-Hammami’s Southern California toy stores called The Game Chest, and you'll find the experience is as important as a purchase.
The supply chain disruption is shorthand for problems from factory closures to workers who are not working anymore.
New research in the INFORMS journal Management Science finds that the U.S. Food and Drug Administration (FDA) could enhance public safety by employing new data-driven approaches to identify adverse effects of drugs faster and more reliably, which would improve the regulatory decision-making and oversight processes. This approach would substantially contrast with the current FDA approaches for monitoring drug safety, which suffers major drawbacks (e.g., they are based on voluntary reports that can result in inaccurate or untimely decisions).
Commercial brokers have always crunched data to make sure an investment makes financial sense. But high-tech analytics can take that analysis to a new level.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today MagazineAnalytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine